NCT03594422 2025-02-27A Study of HQP1351 in Patients With GIST or Other Solid TumorsAscentage Pharma Group Inc.Phase 1 Recruiting100 enrolled
NCT06640361 2024-12-27A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.Phase 3 Recruiting40 enrolled